Efficacy and safety of sulbactam–durlobactam versus colistin for the treatment of patients with serious infections caused by Acinetobacter baumannii–calcoaceticus complex: a multicentre, randomised, active-controlled, phase 3, non-inferiority clinical trial (ATTACK)
| Autor: | Kaye, Keith S *, Shorr, Andrew F, Wunderink, Richard G, Du, Bin, Poirier, Gabrielle E, Rana, Khurram, Miller, Alita, Lewis, Drew, O'Donnell, John, Chen, Lan, Reinhart, Harald, Srinivasan, Subasree, Isaacs, Robin, Altarac, David |
|---|---|
| Zdroj: | In The Lancet Infectious Diseases September 2023 23(9):1072-1084 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|